Jubilant Pharmova Ltd.’s revenue in Q4FY23 rose 10% to ₹ 1,678 crores. Consolidated Loss After Tax came at ₹ 101 crores in Q4FY23.
Jubilant Pharmova Q4FY23; Reported Losses
Tags: Radiopharma
Related Post
- Grasim Industries Ltd Q2FY25; 46% fall in Profits
Grasim Industries Limited is the flagship company of the Aditya Birla group, it ranks amongst…
-
Graphite India Ltd Q2FY25; 76% fall in Profits
Graphite India Ltd is mainly engaged in the business of manufacturing and selling of graphite…
-
Granules India Ltd Q2FY25; 5% fall in Profits
Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of…